Literature DB >> 25975957

Drug repositioning and repurposing: terminology and definitions in literature.

Joris Langedijk1, Aukje K Mantel-Teeuwisse2, Diederick S Slijkerman3, Marie-Hélène D B Schutjens4.   

Abstract

Drug repositioning and similar terms have been a trending topic in literature and represent novel drug development strategies. We analysed in a quantitative and qualitative manner how these terms were used and defined in the literature. In total, 217 articles referred to 'drug repositioning', 'drug repurposing', 'drug reprofiling', 'drug redirecting' and/or 'drug rediscovery'. Only 67 included a definition ranging from brief and general to extensive and specific. No common definition was identified. Nevertheless, four common features were found: concept, action, use and product. The different wording used for these features often leads to essential differences in meaning between definitions. In case a clear definition is needed, for example from a legal or regulatory perspective, the features can provide further guidance.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25975957     DOI: 10.1016/j.drudis.2015.05.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  63 in total

Review 1.  The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug.

Authors:  Mandy Juarez; Alejandro Schcolnik-Cabrera; Alfonso Dueñas-Gonzalez
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

Review 2.  Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.

Authors:  Anna E Kersh; Spencer Ng; Yun Min Chang; Maiko Sasaki; Susan N Thomas; Haydn T Kissick; Gregory B Lesinski; Ragini R Kudchadkar; Edmund K Waller; Brian P Pollack
Journal:  J Clin Pharmacol       Date:  2017-11-14       Impact factor: 3.126

Review 3.  From gene networks to drugs: systems pharmacology approaches for AUD.

Authors:  Laura B Ferguson; R Adron Harris; Roy Dayne Mayfield
Journal:  Psychopharmacology (Berl)       Date:  2018-03-01       Impact factor: 4.530

Review 4.  Programmed Cell Death, from a Cancer Perspective: An Overview.

Authors:  Abhay P Mishra; Bahare Salehi; Mehdi Sharifi-Rad; Raffaele Pezzani; Farzad Kobarfard; Javad Sharifi-Rad; Manisha Nigam
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

Review 5.  Drug repurposing for antimicrobial discovery.

Authors:  Maya A Farha; Eric D Brown
Journal:  Nat Microbiol       Date:  2019-03-04       Impact factor: 17.745

6.  Current and promising pharmacotherapeutic options for candidiasis.

Authors:  Liliana Scorzoni; Beth Burgwyn Fuchs; Juliana Campos Junqueira; Eleftherios Mylonakis
Journal:  Expert Opin Pharmacother       Date:  2021-02-04       Impact factor: 3.889

Review 7.  Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Authors:  Vinayak Palve; Yi Liao; Lily L Remsing Rix; Uwe Rix
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

Review 8.  Machine learning approaches and databases for prediction of drug-target interaction: a survey paper.

Authors:  Maryam Bagherian; Elyas Sabeti; Kai Wang; Maureen A Sartor; Zaneta Nikolovska-Coleska; Kayvan Najarian
Journal:  Brief Bioinform       Date:  2021-01-18       Impact factor: 11.622

Review 9.  Drug repositioning and repurposing for Alzheimer disease.

Authors:  Clive Ballard; Dag Aarsland; Jeffrey Cummings; John O'Brien; Roger Mills; Jose Luis Molinuevo; Tormod Fladby; Gareth Williams; Pat Doherty; Anne Corbett; Janet Sultana
Journal:  Nat Rev Neurol       Date:  2020-09-16       Impact factor: 42.937

Review 10.  Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

Authors:  Natalie K Boyd; Chengwen Teng; Christopher R Frei
Journal:  Front Cell Infect Microbiol       Date:  2021-05-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.